ArticleAlzheimer's research & therapy2021

Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease.

Freyja Aichholzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.